Big pharma and patient care – Commercial Appeal

About a decade ago when I was newly settled into private practice in Memphis, a representative for a drug company marketing a new and powerful antibiotic stood in my office and asked whether I would like to attend a consultants’ meeting about the drug in Washington. He told me I was a “thought leader” in […]